跳至主要内容
临床试验/NCT01507441
NCT01507441已完成不适用

Whole Exon Sequencing of Down Syndrome Acute Myeloid Leukemia

Children's Oncology Group0 个研究点目标入组 10 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
主要终点
Identification of unique mutations through whole-genome sequencing

研究概览

简要总结

RATIONALE: Studying samples of blood, tissue, and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies DNA samples from patients with Down syndrome and acute myeloid leukemia treated on COG-AAML0431 clinical trial.

详细描述

OBJECTIVES:

  • To identify new genetic abnormalities associated with acute myeloid leukemia (AML) in patients with Down syndrome through whole-genome sequencing.

OUTLINE: This is a multicenter study.

Extracted DNA and RNA from cryopreserved specimens are analyzed for genomic sequencing, gene mutation, and microarray analysis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Identification of unique mutations through whole-genome sequencing

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验